Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 1/25
Result 613 decisions over 120 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
11 Jun 2020
CVP, Critical Care
Sold, plan not stated
2,249
$163.25K
6.1%
1 Jun 2020
CVP, TAVR
Sold, plan not stated
10,698
$805.56K
2.9%
18 May 2020
CVP, Japan & Intercontinental
Sold, plan not stated
1,717
$372.04K
5.2%
15 May 2020
CVP,Strategy/Corp Development
Sold, plan not stated
4,358
$937.67K
15.2%
14 May 2020
CVP, Critical Care
Sold, plan not stated
1,116
$237.36K
8.3%
13 May 2020
CVP, Critical Care
Sold, plan not stated
750
$162.70K
5.3%
11 May 2020
CVP, Japan & Intercontinental
Sold, plan not stated
3,883
$850.50K
10.8%
8 May 2020
Chairman & CEO
Sold, plan not stated
22,850
$5.02M
29.7%
8 May 2020
CVP,Strategy/Corp Development
Sold, plan not stated
5,372
$1.19M
19.3%
1 May 2020
CVP, TAVR
Sold, plan not stated
3,566
$766.69K
2.9%
27 Apr 2020
CVP, EMEA, Canada, Latin Amer
Sold, plan not stated
3,470
$775.55K
7.6%
16 Apr 2020
CVP, Critical Care
Sold, plan not stated
1,116
$242.07K
7.0%
13 Apr 2020
CVP, Japan & Intercontinental
Sold, plan not stated
3,911
$833.00K
11.1%
7 Apr 2020
Chairman & CEO
Sold, plan not stated 12×
22,850
$4.62M
32.7%
3 Apr 2020
CVP,Strategy/Corp Development
Sold, plan not stated
5,369
$979.52K
20.5%
1 Apr 2020
CVP, TAVR
Sold, plan not stated
3,566
$644.88K
2.9%
1 Apr 2020
CVP, EMEA, Canada, Latin Amer
Sold, plan not stated
3,470
$627.51K
7.6%
30 Mar 2020
CVP, Japan & Intercontinental
Sold, plan not stated
4,948
$980.28K
13.7%
23 Mar 2020
CVP, Critical Care
Sold, plan not stated
1,116
$181.85K
6.6%
19 Mar 2020
Chairman & CEO
Sold, plan not stated 14×
22,850
$4.06M
32.7%
6 Mar 2020
CVP,Strategy/Corp Development
Sold, plan not stated
5,369
$1.08M
20.6%
2 Mar 2020
CVP, TAVR
Sold, plan not stated
3,566
$738.16K
2.9%
27 Feb 2020
CVP, EMEA, Canada, Latin Amer
Sold, plan not stated
3,470
$754.83K
7.7%
18 Feb 2020
CVP, Critical Care
Sold, plan not stated
2,500
$571.43K
12.9%
10 Feb 2020
Chairman & CEO
Sold, plan not stated
22,850
$5.25M
32.7%
7 Feb 2020
CVP,Strategy/Corp Development
Sold, plan not stated
5,369
$1.27M
20.6%
5 Feb 2020
CVP, Japan & Intercontinental
Sold, plan not stated
4,650
$1.06M
12.6%
3 Feb 2020
CVP, TAVR
Sold, plan not stated
3,566
$782.74K
2.9%
3 Feb 2020
CVP, EMEA, Canada, Latin Amer
Sold, plan not stated
3,470
$761.67K
7.7%
3 Feb 2020
CVP, Critical Care
Sold, plan not stated
2,500
$548.75K
12.9%
10 Jan 2020
CVP,Strategy/Corp Development
Sold, plan not stated
5,369
$1.27M
20.6%
7 Jan 2020
CVP, Chief Financial Officer
Sold, plan not stated
7,500
$1.76M
43.0%
6 Jan 2020
CVP, Japan & Intercontinental
Sold, plan not stated
4,650
$1.07M
12.6%
3 Jan 2020
Chairman & CEO
Sold, plan not stated
22,850
$5.29M
32.7%
2 Jan 2020
CVP, TAVR
Sold, plan not stated
8,568
$1.97M
6.8%
16 Dec 2019
CVP, Critical Care
Sold, plan not stated
2,500
$585.69K
12.8%
12 Dec 2019
Chairman & CEO
Sold, plan not stated
22,850
$5.25M
32.7%
11 Dec 2019
CVP,Strategy/Corp Development
Sold, plan not stated
5,369
$1.23M
20.6%
10 Dec 2019
CVP, Chief Financial Officer
Sold, plan not stated
7,500
$1.75M
43.0%
9 Dec 2019
CVP, TAVR
Sold, plan not stated
6,724
$1.60M
5.4%
9 Dec 2019
CVP, Japan & Intercontinental
Sold, plan not stated
4,650
$1.11M
12.6%
15 Nov 2019
Chairman & CEO
Sold, plan not stated
22,850
$5.59M
23.9%
15 Nov 2019
CVP, Critical Care
Sold, plan not stated
2,500
$605.35K
12.8%
12 Nov 2019
CVP, Chief Financial Officer
Sold, plan not stated
7,500
$1.76M
43.0%
8 Nov 2019
CVP,Strategy/Corp Development
Sold, plan not stated
5,369
$1.26M
20.6%
6 Nov 2019
CVP,Strategy/Corp Development
Sold, plan not stated
10,500
$2.46M
33.6%
5 Nov 2019
CVP, Japan & Intercontinental
Sold, plan not stated
4,650
$1.09M
12.6%
1 Nov 2019
CVP, TAVR
Sold, plan not stated
6,716
$1.61M
5.4%
30 Oct 2019
Chairman & CEO
Sold, plan not stated
22,850
$5.46M
23.9%
29 Oct 2019
CVP, Chief Financial Officer
Sold, plan not stated
7,500
$1.76M
43.0%
Showing 351–400 of 613. ← Newer Page 8 of 13 Older →